Diabetes remission possible with GLP-1 drugs, Italian study confirms
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
How COVID mRNA vaccines may make cancer treatments more effective
A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers…
New drug combination shows promise in treating colorectal cancer
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it…
Researchers develop a novel approach to monitor CD8⁺ T cell activity over time
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key…
Blocking two enzymes weakens prostate tumors and boosts drug effectiveness
A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment…
Innovative approaches target PAR2 receptor to alleviate gut pain
Abdominal pain is a hallmark of many digestive disorders, including inflammatory bowel disease and irritable bowel syndrome. In…
Azelastine nasal spray prevents COVID-19 and rhinovirus infections
Variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
Study provides new insights into the mechanisms of fetal membrane healing
When a pregnant woman’s water breaks too early, it often leads to preterm birth, with no effective method…
AlphaFold3 predicts bitter taste receptor structures with greater accuracy
Receptor proteins, expressed on the cell surface or within the cell, bind to different signaling molecules, known as…
Study:Half of adults without diabetes taking weight-loss drug discontinue treatment within a year
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…